TY  - GEN
AU  - Segura-Collar, Berta
AU  - Hiller-Vallina, Sara
AU  - Dios Huerta, Olaya de
AU  - Caamaño-Moreno, Marta
AU  - Mondejar-Ruescas, Lucia
AU  - Sepulveda-Sanchez, Juan M
AU  - Gargini, Ricardo
PY  - 2023
DO  - 10.1186/s40478-023-01569-y
UR  - http://hdl.handle.net/20.500.12105/16242
AB  - Glial-origin brain tumors, including glioblastomas (GBM), have one of the worst prognoses due to their rapid and fatal progression. From an oncological point of view, advances in complete surgical resection fail to eliminate the entire tumor and the...
LA  - eng
PB  - BioMed Central (BMC)
KW  - Glioblastoma
KW  - Glioma
KW  - Neoantigen vaccine
KW  - mRNA vaccine
KW  - Virotherapy
KW  - Immunotherapy
KW  - Tumor microenvironment
KW  - Suppressive myeloid cells
KW  - Immune checkpoint inhibitors
KW  - PD-1
KW  - PD-L1
KW  - Glioblastoma
KW  - Cancer Vaccines
KW  - Glioma
KW  - Brain Neoplasms
KW  - Humans
KW  - Immunologic Factors
KW  - Immunotherapy
KW  - Tumor Microenvironment
TI  - Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
TY  - review article
ER  -